Development of taxane resistance in a panel of human lung cancer cell lines

Toxicology in Vitro

Volumn 22, Issue 5, 2008, Pages 1234-1241

  Breen, Laura ^a   Murphy, Lisa ^a   Keenan, Joanne ^a   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Drug resistance; Lung cancer; Taxol; Taxotere

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; ELACRIDAR; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; SULINDAC; TAXANE DERIVATIVE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CLINICAL STUDY; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFICACY; HUMAN; HUMAN CELL; IC 50; LUNG NON SMALL CELL CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BRIDGED COMPOUNDS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; P-GLYCOPROTEIN; TAXOIDS;

EID: 44949224333     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.04.005     Document Type: Article

References (40)

1. Androulakis N., Kouroussis C., Kakolyris S., Tzannes S., Papadakis E., Papadimitriou C., Geroyianni A., Georgopoulou T., Dimopoulou I., Souglakos J., Kotsakis A., Vardakis N., Hatzidaki D., and Georgoulias V. Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 9 (1998) 1127-1130
2. Arai, T., Miyoshi, Y., Kim, S.J., Akazawa, K., Maruyama, N., Taguchi, T., Tamaki, Y., Noguchi, S., 2007. Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
3. Belotti D., Rieppi M., Nicoletti M.I., Casazza A.M., Fojo T., Taraboletti G., and Giavazzi R. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clinical cancer research: an official journal of the American Association for Cancer Research 2 (1996) 1725-1730
4. Calderoni A., and Cerny T. Taxanes in lung cancer: a review with focus on the European experience. Critical reviews in oncology/hematology 38 (2001) 105-127
5. Chiou J.F., Liang J.A., Hsu W.H., Wang J.J., Ho S.T., and Kao A. Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer. Lung 181 (2003) 267-273
6. Chrystal K., Cheong K., and Harper P. Chemotherapy of small cell lung cancer: state of the art. Current opinion in oncology 16 (2004) 136-140
7. Coles B.F., and Kadlubar F.F. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?. BioFactors (Oxford, England) 17 (2003) 115-130
8. Danesi R., de Braud F., Fogli S., de Pas T.M., Di Paolo A., Curigliano G., and Del Tacca M. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. Pharmacological reviews 55 (2003) 57-103
9. de Bruin M., Miyake K., Litman T., Robey R., and Bates S.E. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer letters 146 (1999) 117-126
10. Diaz J.F., Valpuesta J.M., Chacon P., Diakun G., and Andreu J.M. Changes in microtubule protofilament number induced by Taxol binding to an easily accessible site. Internal microtubule dynamics. The Journal of biological chemistry 273 (1998) 33803-33810
11. Duffy C.P., Elliott C.J., O'Connor R.A., Heenan M.M., Coyle S., Cleary I.M., Kavanagh K., Verhaegen S., O'Loughlin C.M., NicAmhlaoibh R., and Clynes M. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs) (Oxford, England: 1990). European journal of cancer 34 (1998) 1250-1259
12. Filipits M. Mechanisms of cancer: multidrug resistance. Drug Discovery Today: Disease Mechanisms 1 (2004) 229-234
13. Fojo T., and Menefee M. Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 18 Suppl. 5 (2007) 3-8
14. Glynn S.A., Gammell P., Heenan M., O'Connor R., Liang Y., Keenan J., and Clynes M. A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin. British journal of cancer 91 (2004) 1800-1807
15. l2 is the guardian of microtubule integrity. Cancer research 57 (1997) 229-233
16. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. The lancet oncology 3 (2002) 461-469
17. Hyafil F., Vergely C., Du Vignaud P., and Grand-Perret T. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer research 53 (1993) 4595-4602
18. Ikuta K., Takemura K., Kihara M., Naito S., Lee E., Shimizu E., and Yamauchi A. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Oncology reports 13 (2005) 1229-1234
19. Kavallaris M., Kuo D.Y., Burkhart C.A., Regl D.L., Norris M.D., Haber M., and Horwitz S.B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. The Journal of clinical investigation 100 (1997) 1282-1293
20. Khuri F.R., and Cohen V. Molecularly targeted approaches to the chemoprevention of lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 10 (2004) 4249s-4253s
21. Laemmli U.K., and Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. Journal of Molecular Biology 80 (1973) 575-599
22. Law E., Gilvarry U., Lynch V., Gregory B., Grant G., and Clynes M. Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer genetics and cytogenetics 59 (1992) 111-118
23. Liang Y., Meleady P., Cleary I., McDonnell S., Connolly L., and Clynes M. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness (Oxford, England: 1990). European journal of cancer 37 (2001) 1041-1052
24. Longley D.B., and Johnston P.G. Molecular mechanisms of drug resistance. The Journal of pathology 205 (2005) 275-292
25. Martello L.A., Verdier-Pinard P., Shen H.J., He L., Torres K., Orr G.A., and Horwitz S.B. Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation. Cancer research 63 (2003) 1207-1213
26. Martin A., and Clynes M. Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays. Cytotechnology 11 (1993) 49-58
27. Mathieu A., Remmelink M., D'Haene N., Penant S., Gaussin J.F., Van Ginckel R., Darro F., Kiss R., and Salmon I. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GST-mu, and GST-pi. Cancer 101 (2004) 1908-1918
28. McGrogan, B.T., Gilmartin, B., Carney, D.N., McCann, A., 2007. Taxanes, microtubules and chemoresistant breast cancer. Biochimica et biophysica acta.
29. Mechetner E., Kyshtoobayeva A., Zonis S., Kim H., Stroup R., Garcia R., Parker R.J., and Fruehauf J.P. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clinical cancer research: an official journal of the American Association for Cancer Research 4 (1998) 389-398
30. Murphy, L., Clynes, M., Keenan, J., 2008. Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line. BBA - Proteins and Proteomics, doi:10.1016/j.bbapap.2008.04.014.
31. O'Connor R., O'Leary M., Ballot J., Collins C.D., Kinsella P., Mager D.E., Arnold R.D., O'Driscoll L., Larkin A., Kennedy S., Fennelly D., Clynes M., and Crown J. A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. Cancer chemotherapy and pharmacology 59 (2007) 79-87
32. Parekh H., Wiesen K., and Simpkins H. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochemical pharmacology 53 (1997) 461-470
33. Rigas J.R. Taxane-platinum combinations in advanced non-small cell lung cancer: a review. The oncologist 9 suppl. 2 (2004) 16-23
34. Sato S., Kigawa J., Kanamori Y., Itamochi H., Oishi T., Shimada M., Iba T., Naniwa J., Uegaki K., and Terakawa N. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells. Cancer chemotherapy and pharmacology 53 (2004) 247-252
35. Scagliotti G.V., Novello S., and Selvaggi G. Multidrug resistance in non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO 10 suppl. 5 (1999) S83-S86
36. Scripture C.D., Szebeni J., Loos W.J., Figg W.D., and Sparreboom A. Comparative in vitro properties and clinical pharmacokinetics of Paclitaxel following the administration of taxol(r) and paxene(r). Cancer biology & therapy 4 (2005) 555-560
37. Simon, S.M., Schindler, M., 1994. Cell biological mechanisms of multidrug resistance in tumors. In: Proceedings of the National Academy of Sciences of the United States of America 91, 3497-3504.
38. Tan B., Piwnica-Worms D., and Ratner L. Multidrug resistance transporters and modulation. Current opinion in oncology 12 (2000) 450-458
39. Towbin, H., Staehelin, T., Gordon, J., 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. In: Proceedings of the National Academy of Sciences of the United States of America 76, 4350-4354.
40. Wang T.H., Wang H.S., and Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88 (2000) 2619-2628